BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6211948)

  • 1. Structure, function, and metabolism of leukotriene constituents of SRS-A.
    Lewis RA; Austen KF; Drazen JM; Soter NA; Figueiredo JC; Corey EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():137-51. PubMed ID: 6211948
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the actions of leukotriene E4 with those of leukotrienes B4, C4, and D4 on guinea pig lung and ileal smooth muscle in vitro.
    Piper PJ; Samhoun MN
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():127-31. PubMed ID: 6303079
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation of the tracheal and lung parenchymal effects of synthetic leukotrienes in the guinea pig.
    Wasserman MA; Weichman BM; Woodward DF; Muccitelli RM; Gleason JG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():133-7. PubMed ID: 6303081
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary and vascular effects of leukotrienes imply involvement in asthma and inflammation.
    Hedqvist P; Dahlén SE
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():27-32. PubMed ID: 6221536
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukotriene D4 (LTD4) antagonists: structure activity relationships of stable phenylsubstituted leukotriene analogs.
    von Sprecher A; Breltenstein W; Beck A; Anderson W; Bray MA; Märkl F
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():647-50. PubMed ID: 2526552
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological activity of leukotriene C4 in guinea pigs: in vitro and in vivo studies.
    Folco GC; Omini C; Viganó T; Brunelli G; Rossoni G; Berti F
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():153-67. PubMed ID: 6211949
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary and vascular actions of leukotrienes.
    Hedqvist P; Dahlén SE; Björk J
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():187-200. PubMed ID: 6283842
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of leukotriene C4 bronchoconstriction by beta-adrenoceptor antagonists in the guinea pig.
    Bongrani S; Razzetti R; Folco GC; Schiantarelli P
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():173-8. PubMed ID: 6303085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of indomethacin on leukotriene-induced contractile responses in guinea pig trachea and lung parenchyma strips].
    Uchida Y; Ishihara Y; Kitamura S; Takaku F
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Oct; 22(10):885-9. PubMed ID: 6530854
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology of the C-6-sulfidopeptide leukotrienes.
    Lewis RA; Lee CW; Levine L; Morgan RA; Weiss JW; Drazen JM; Oh H; Hoover D; Corey EJ; Austen KF
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():15-26. PubMed ID: 6221518
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukotriene receptors in sheep respiratory tissue.
    Cuthbert NJ; Abram TS; Gardiner PJ
    Ann N Y Acad Sci; 1991; 629():405-6. PubMed ID: 1659284
    [No Abstract]   [Full Text] [Related]  

  • 12. Quinone derivatives: synthesis and structure-activity relations of a novel class of eicosanoid antagonists, AA-2414 and its analogs.
    Terao S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():651-4. PubMed ID: 2526553
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasoactive intestinal peptide counteracts leukotriene D4-induced contractions of guinea pig trachea, lung, and pulmonary artery.
    Hamasaki Y; Saga T; Mojarad M; Said SI
    Trans Assoc Am Physicians; 1983; 96():406-11. PubMed ID: 6679961
    [No Abstract]   [Full Text] [Related]  

  • 14. Tachyphylaxis of leukotriene C4-induced release of thromboxane A2 from guinea pig lung parenchyma and isoproterenol inhibition of this release.
    Zijlstra FJ; Bonta IL; Vincent JE
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():167-71. PubMed ID: 6221589
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative biological activity of natural and synthetic leukotrienes.
    Baker SR; Boot JR; Dawson W; Jamieson WB; Osborne DJ; Sweatman WJ
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():223-7. PubMed ID: 6283843
    [No Abstract]   [Full Text] [Related]  

  • 16. The actions of leukotrienes B4, C4, D4 and E4 in the lung.
    Piper PJ; Samhoun MN
    Agents Actions Suppl; 1983; 13():173-5. PubMed ID: 6307018
    [No Abstract]   [Full Text] [Related]  

  • 17. Analogs of leukotrienes and related lipoxygenase products.
    Toda M; Arai Y; Hayashi M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():427-36. PubMed ID: 2992246
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonists of SRS-A and leukotrienes.
    Sheard P; Holroyde MC; Ghelani AM; Bantick JR; Lee TB
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():229-35. PubMed ID: 6211955
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific allergen induces contraction of bronchi and formation of leukotrienes C4, D4, and E4 in human asthmatic lung.
    Hansson G; Björck T; Dahlén SE; Hedqvist P; Granström E; Dahlén B
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():153-9. PubMed ID: 6303083
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological properties of BL-5255Z, an antiallergy compound that blocks SRS activity.
    Gillespie E; Dungan KW
    Monogr Allergy; 1983; 18():211-9. PubMed ID: 6196627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.